A case of severe hyponatremia induced by duloxetine and ziprasidone.
- Author:
Rui-Ming LI
1
;
Cong WANG
;
Zhi-Wei LIU
;
Bin ZHAO
Author Information
1. Department of Emergency Medicine, Beijing Jishuitan Hospital, Beijing 100035, China.
- Publication Type:Case Reports
- MeSH:
Antidepressive Agents;
adverse effects;
Antipsychotic Agents;
adverse effects;
Creatine Kinase;
blood;
Depressive Disorder, Major;
drug therapy;
Duloxetine Hydrochloride;
Female;
Humans;
Hyponatremia;
chemically induced;
Middle Aged;
Piperazines;
adverse effects;
Thiazoles;
adverse effects;
Thiophenes;
adverse effects
- From:
Chinese Medical Journal
2012;125(20):3750-3751
- CountryChina
- Language:English
-
Abstract:
We report a case of severe hyponatremia related to duloxetine and ziprasidone. A 50-year-old woman on duloxetine and ziprasidone treatment for major depressive disorder developed polydipsia, polyuria, and two episodes of seizures, followed by admission to the emergency department on the 10th day of treatment. Laboratory investigations revealed elevated creatine kinase (CK) as well as hyponatremia, hypo-osmolality, and increased urine sodium. Syndrome of Inappropriate Antidiuretic Hormone (SIADH) was considered, although urine osmolality was not measured. Duloxetine and ziprasidone were discontinued and the CK gradually normalized after correction of hyponatremia. Clinicians should be aware of the possibility of antipsychotic-induced hyponatremia, particularly in patients with symptoms of polydipsia.
